Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

BB Biotech's Dr Daniel Koller discusses the fund's investment strategy and performance

Daniel Koller, Head Investment Management Team, outlines BB Biotech’s investment strategy and performance in an interview with Proactive London.
29.01.2024 - Daniel Koller
BB Biotech's Dr Daniel Koller discusses the fund's investment strategy and performance

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993